A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
- Status
- COMPLETED
- Phase
- PHASE4
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
- Status
- UNKNOWN
- Phase
- PHASE4
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML
- Status
- TERMINATED
- Phase
- PHASE1
Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
EDOCH Alternating With DHAP for New Diagnosed Younger MCL
- Status
- COMPLETED
- Phase
- PHASE4
Optimal Treatment Strategy Based on for Pediatric AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
- Status
- COMPLETED
- Phase
- PHASE2
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1